Soufflé Therapeutics
Soufflé Therapeutics develops targeted RNA medicines for patients with muscle disorders and heart failure.
$135MSeries B
ParticipantBC
Breyer Capital
Activity from announced rounds
All recorded activity
- Rounds participated in
- 7
- Confirmed lead rounds
- 0 4 roles undisclosed
- New companies
- 7 First participation on record · 0 follow-on
- Funding in participating rounds
- $867M 7 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
7 in all activityNetwork Bio
Builds AI models trained on patient tissue and clinical data for disease diagnostics
$50MStrategic
Role not disclosedParcelBio
Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology
$13MSeed
Role not disclosedOpenEvidence
Provides AI-powered medical search engine for clinicians
$250MSeries D
Role not disclosedSoley Therapeutics
Uses cells as sensors to uncover first-in-class medicines
$200MSeries C
Role not disclosedYoco
Yoco provides card payments, point-of-sale software and business tools for South African merchants.
$83MSeries C
ParticipantHomeward
Homeward provides cash offers and bridge financing for homebuyers and sellers.
$136MSeries B
Participant